Patents by Inventor Harvey B. Buck, Jr.

Harvey B. Buck, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11318493
    Abstract: A slot die shim for use with a slot die, the slot die shim including a first channel configured to receive a first coating, a second channel configured to receive a second coating, and a third channel configured to receive a third coating. The slot die shim simultaneously dispenses the first coating through the first channel, the second coating through the second channel, and the third coating through the third channel onto a substrate. The coatings can be applied at different flow rates and include different test reagents. A vacuum force is applied to the first, second, and third coatings to control a width and a thickness of each of the coatings and a gap or distance between the coatings. The first, second, and third coatings are placed near one another or directly in contact with one another to minimize the area required for the coatings.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: May 3, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Harvey B. Buck, Jr., Randall K. Riggles, Thomas D. Hahn, Mike Limbaugh, Timothy Owens
  • Patent number: 10996184
    Abstract: A biosensor including a capillary chamber having an inner boundary, a working electrode including an effective working electrode portion positioned within the capillary chamber, and a counter electrode including an effective counter electrode portion positioned within the capillary chamber, and with the working and counter electrodes each having a neck that constitutes the sole portion of the electrodes that extends across the inner boundary and out of the capillary chamber. In one embodiment, the effective working electrode portion defines an average working electrode width, and the working electrode neck defines a working electrode neck width that is reduced relative to the average working electrode width.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: May 4, 2021
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Randall K. Riggles, Abner D. Joseph, Scott E. Carpenter, Harvey B. Buck, Jr., Georgeta C. Lica, Terry A. Beaty
  • Patent number: 10716504
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: July 21, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
  • Publication number: 20200147638
    Abstract: A slot die shim for use with a slot die, the slot die shim including a first channel configured to receive a first coating, a second channel configured to receive a second coating, and a third channel configured to receive a third coating. The slot die shim simultaneously dispenses the first coating through the first channel, the second coating through the second channel, and the third coating through the third channel onto a substrate. The coatings can be applied at different flow rates and include different test reagents. A vacuum force is applied to the first, second, and third coatings to control a width and a thickness of each of the coatings and a gap or distance between the coatings. The first, second, and third coatings are placed near one another or directly in contact with one another to minimize the area required for the coatings.
    Type: Application
    Filed: April 10, 2018
    Publication date: May 14, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, JR., Randall K. Riggles, Thomas D. Hahn, Mike Limbaugh, Timothy Owens
  • Patent number: 10478556
    Abstract: Methods and systems are disclosed for estimating a glucose level of a person having diabetes and selecting automatically open-loop and closed-loop control for a connected therapy delivery device. The method may comprise analyzing measured glucose results and corresponding impedance values received from a glucose sensor coupled to the person with a probability analysis tool implemented by a microcontroller to determine a total quality score that is based on the minimum constraint of a probability of glucose sensor accuracy determined measured glucose results and a probability of sensing quality determined from the impedance values. The microcontroller may estimate the glucose level of the person with a recursive filter based on the plurality of measured glucose results weighted with the total quality score and select automatically either open-loop control or closed-loop control for the connected therapy delivery device based on the value of the total quality score.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: November 19, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, Jr., David L. Duke
  • Patent number: 10197524
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: February 5, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, Jr., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Publication number: 20180348159
    Abstract: A biosensor including a capillary chamber having an inner boundary, a working electrode including an effective working electrode portion positioned within the capillary chamber, and a counter electrode including an effective counter electrode portion positioned within the capillary chamber, and with the working and counter electrodes each having a neck that constitutes the sole portion of the electrodes that extends across the inner boundary and out of the capillary chamber. In one embodiment, the effective working electrode portion defines an average working electrode width, and the working electrode neck defines a working electrode neck width that is reduced relative to the average working electrode width.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Inventors: Randall K. Riggles, Abner D. Joseph, Scott E. Carpenter, Harvey B. Buck, JR., Georgeta C. Lica, Terry A. Beaty
  • Patent number: 10041902
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: August 7, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, Jr., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Patent number: 9976977
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: May 22, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, Jr., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Publication number: 20170357766
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Inventors: Nicole BERNINI, Harvey B. BUCK, JR., Andreas EBERHART, Sybille FROECH, Otto GAA, Michael MARQUANT, Juergen RASCH-MENGES, Bernd ROESICKE, Joerg SCHERER
  • Patent number: 9773093
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: September 26, 2017
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
  • Publication number: 20170252513
    Abstract: Methods and systems are disclosed for estimating a glucose level of a person having diabetes and selecting automatically open-loop and closed-loop control for a connected therapy delivery device. The method may comprise analyzing measured glucose results and corresponding impedance values received from a glucose sensor coupled to the person with a probability analysis tool implemented by a microcontroller to determine a total quality score that is based on the minimum constraint of a probability of glucose sensor accuracy determined measured glucose results and a probability of sensing quality determined from the impedance values. The microcontroller may estimate the glucose level of the person with a recursive filter based on the plurality of measured glucose results weighted with the total quality score and select automatically either open-loop control or closed-loop control for the connected therapy delivery device based on the value of the total quality score.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 7, 2017
    Inventors: Harvey B. Buck, JR., David L. Duke
  • Patent number: 9594045
    Abstract: Methods are disclosed for measuring an analyte concentration in a fluidic sample. Such methods further allow one to provide an error code or correct and/or compensate for interferents such as an antioxidant before providing an analyte concentration. The measurement methods utilize information obtained from test sequences having at least one DC block, such as a slow-ramped bi-polar waveform, where a closed circuit condition is maintained during the DC block. The methods use information relating to status of a redox mediator feature during the electrochemical analysis to provide an antioxidant failsafe if the antioxidant is interfering with the analyte concentration. Also disclosed are devices, apparatuses and systems incorporating the various measurement methods.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: March 14, 2017
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, Jr., Scott E. Carpenter, Zheng Zheng Pan
  • Publication number: 20160320330
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Application
    Filed: June 15, 2016
    Publication date: November 3, 2016
    Inventors: Harvey B. Buck, JR., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Publication number: 20160320329
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Application
    Filed: June 15, 2016
    Publication date: November 3, 2016
    Inventors: Harvey B. Buck, JR., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Publication number: 20160305902
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Application
    Filed: June 15, 2016
    Publication date: October 20, 2016
    Inventors: Harvey B. Buck, JR., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Patent number: 9395322
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: July 19, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Harvey B. Buck, Jr., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Publication number: 20160041117
    Abstract: Methods are disclosed for scaling body fluid analysis data to correct and/or compensate for confounding variables such as hematocrit (Hct), temperature, variations in electrode conductivity or combinations thereof before providing an analyte concentration. The scaling methods utilize current response data obtained from an AC block applied prior to a DC block to minimize the impact of such confounding variables upon the observed DC current response before creating descriptors or algorithms. The scaling methods therefore compensate the measured DC current by using data from the AC block made on the same sample. Also disclosed are devices, apparatuses and systems incorporating the various scaling methods.
    Type: Application
    Filed: September 11, 2015
    Publication date: February 11, 2016
    Applicant: ROCHE DIABETES CARE, INC.
    Inventors: Harvey B. Buck, Jr., Scott E. Carpenter, Zheng Zheng Pan, Rene Valverde-Ventura
  • Publication number: 20160011140
    Abstract: Methods are disclosed for measuring an analyte concentration in a fluidic sample. Such methods further allow one to provide an error code or correct and/or compensate for interferents such as an antioxidant before providing an analyte concentration. The measurement methods utilize information obtained from test sequences having at least one DC block, such as a slow-ramped bi-polar waveform, where a closed circuit condition is maintained during the DC block. The methods use information relating to status of a redox mediator feature during the electrochemical analysis to provide an antioxidant failsafe if the antioxidant is interfering with the analyte concentration. Also disclosed are devices, apparatuses and systems incorporating the various measurement methods.
    Type: Application
    Filed: September 11, 2015
    Publication date: January 14, 2016
    Applicant: ROCHE DIABETES CARE, INC.
    Inventors: Harvey B. Buck, JR., Scott E. Carpenter, Zheng Zheng Pan
  • Publication number: 20150356264
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 10, 2015
    Inventors: Nicole BERNINI, Harvey B. BUCK, JR., Andreas EBERHART, Sybille FROECH, Otto GAA, Michael MARQUANT, Juergen RASCH-MENGES, Bernd ROESICKE, Joerg SCHERER